Pankreatan

Pankreatan is a porcine-derived pancreatic enzyme replacement therapy (PERT) developed and manufactured by Nordmark Pharma GmbH. It contains pancreatin, a biological mixture of essential digestive enzymes including lipase, amylase, and proteases. The drug is indicated for the treatment of pancreatic exocrine insufficiency (PEI), a condition where the pancreas does not produce enough enzymes to digest food properly. Pankreatan is formulated as enteric-coated hard capsules containing microtablets or pellets, designed to release enzymes in the small intestine to aid in the digestion of fats, carbohydrates, and proteins. It is available in various strengths, notably 40,000 Ph. Eur. units of lipase per capsule.

Brand names

Pankreatan

Other names

pancreatinpancreatic enzyme replacement therapyPERT40,000 Ph. Eur. units lipase